After 6 and a half years in working with ASIC and substantial review and consumer testing, DomaCom has finally released it's Equity Release product, a pivotal moment in DomaCom's trajectory.
With the equity release market being worth $30b by 2022 and DomaCom being the ONLY product out there, I expect DomaCom will extract a substantial portion of that market as FUM. More than that, with potential competitors having to undergo the same years-long review by ASIC to get a product out there, this will be a hugely defensible market for DomaCom with them have a 6-year headstart.
I can see why Ord Minett (a tier 1 firm) is beating the drums for a new $2.5 mill raising according to the AFR, with an existing well-known institutional investor doubling down on DomaCom. With the plump cash balance to take advantage of this massive, growing and untapped market, it's looking really good for DomaCom right now.
- Forums
- ASX - By Stock
- 6 years in the making have lead to this moment
After 6 and a half years in working with ASIC and substantial...
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.790M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DCL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online